Menu
Back to Archived Journals » Research and Reports in Endocrine Disorders
Research and Reports in Endocrine Disorders ceased publishing in November 2016. All new submissions can be made to Therapeutics and Clinical Risk Management. All articles that have been published in Research and Reports in Endocrine Disorders will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Research and Reports in Endocrine Disorders
ISSN: 2230-2271
- View all (37)
- Volume 6, 2016 (7)
- Volume 5, 2015 (14)
- Volume 4, 2014 (1)
- Volume 3, 2013 (4)
- Volume 2, 2012 (8)
- Volume 1, 2011 (3)
Journal Articles:
- 37 records -
Association between the biochemical profiles in blood and bone mineral density in Chinese Han population: findings from a cross-sectional study
Chen HX, Wu LB, Meng ZJ
Research and Reports in Endocrine Disorders 2016, 6:59-64
Published Date: 3 November 2016
Prader–Willi syndrome: clinical problems in transition from pediatric to adult care
Crinò A, Fintini D, Bocchini S, Carducci C, Grugni G
Research and Reports in Endocrine Disorders 2016, 6:49-57
Published Date: 18 July 2016
Shared decision making and patient choice for growth hormone therapy: current perspectives
George B, Ayyar V
Research and Reports in Endocrine Disorders 2016, 6:41-48
Published Date: 9 June 2016
Type 1 diabetes: addressing the transition from pediatric to adult-oriented health care
Monaghan M, Baumann K
Research and Reports in Endocrine Disorders 2016, 6:31-40
Published Date: 13 April 2016
Pathophysiology and therapeutic options in osteogenesis imperfecta: an update
Brizola E, Félix TM, Shapiro JR
Research and Reports in Endocrine Disorders 2016, 6:17-30
Published Date: 30 March 2016
Prediction of diabetic foot ulcer healing in type 2 diabetic subjects using routine clinical and laboratory parameters
AlGoblan AS, Alrasheedi IM, Basheir OH, Haider KH
Research and Reports in Endocrine Disorders 2016, 6:11-16
Published Date: 22 March 2016
Profile of alglucosidase alfa in the treatment of Pompe disease: safety, efficacy, and patient acceptability
Schneider I, Zierz S
Research and Reports in Endocrine Disorders 2016, 6:1-9
Published Date: 8 January 2016
Cystic fibrosis-related diabetes: links, challenges, and future directions
Sheikh S, Kelly A
Research and Reports in Endocrine Disorders 2015, 5:157-167
Published Date: 5 November 2015
Hsp90 as a therapeutic target in endocrinology: current evidence
Ratajczak T, Ward BK, Walsh JP, Cluning C
Research and Reports in Endocrine Disorders 2015, 5:141-155
Published Date: 23 October 2015
Prevalence of 25-hydroxyvitamin D deficiency in healthy personnel from an academic institution of an urban area in Costa Rica
Gamboa-Gamboa T, Abarca-Soto G, Jiménez-Montero JG
Research and Reports in Endocrine Disorders 2015, 5:135-140
Published Date: 12 October 2015
Diagnosis and management of insulinoma: current best practice and ongoing developments
Taye A, Libutti SK
Research and Reports in Endocrine Disorders 2015, 5:125-133
Published Date: 25 August 2015
The impact of low-carbohydrate diet on glycemic control in Native Americans
Khairi S, Sagvand BT, Nasser SK
Research and Reports in Endocrine Disorders 2015, 5:119-123
Published Date: 24 August 2015
Managing congenital hyperinsulinism: improving outcomes with a multidisciplinary approach
Ackermann AM, Palladino AA
Research and Reports in Endocrine Disorders 2015, 5:103-117
Published Date: 31 July 2015
Congenital hypothyroidism: current perspectives
Dayal D, Prasad R
Research and Reports in Endocrine Disorders 2015, 5:91-102
Published Date: 17 July 2015
Profile of idursulfase for the treatment of Hunter syndrome
Sestito S, Ceravolo F, Grisolia M, Pascale E, Pensabene L, Concolino D
Research and Reports in Endocrine Disorders 2015, 5:79-90
Published Date: 9 July 2015
Type 2 diabetes mellitus among government employees in Harar, Eastern Ethiopia: a cross-sectional study
Ayana DA, Bacha YD, Roba KT, Kebede DA
Research and Reports in Endocrine Disorders 2015, 5:71-77
Published Date: 6 July 2015
Current and emerging testosterone therapies for male hypogonadism
Wynia B, Kaminetsky JC
Research and Reports in Endocrine Disorders 2015, 5:59-69
Published Date: 7 April 2015
Profile of pegvisomant in the management of acromegaly: an evidence based review of its place in therapy
Bernabeu I, Rodriguez-Gomez IA, Ramos-Levi AM, Marazuela M
Research and Reports in Endocrine Disorders 2015, 5:47-58
Published Date: 16 February 2015
The role of hormonal treatment in type 2 diabetes mellitus
Imam SK
Research and Reports in Endocrine Disorders 2015, 5:31-45
Published Date: 12 February 2015
Diabetes reversal via gene transfer: building on successes in animal models
Gerace D, Martiniello-Wilks R, Simpson AM
Research and Reports in Endocrine Disorders 2015, 5:15-29
Published Date: 29 January 2015
Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence
Jimenez-Montero JG, Haft G
Research and Reports in Endocrine Disorders 2015, 5:1-13
Published Date: 18 December 2014
Clinical potential of eliglustat tartrate in the treatment of type 1 Gaucher disease
Kaplan P
Research and Reports in Endocrine Disorders 2014, 4:1-8
Published Date: 14 May 2014
New options in the treatment of Cushing’s disease: a focus on pasireotide
Poullot AG, Chevalier N
Research and Reports in Endocrine Disorders 2013, 3:31-38
Published Date: 29 May 2013
Visceral adiposity and cardiometabolic risks: epidemic of abdominal obesity in North America
Wimalawansa SJ
Research and Reports in Endocrine Disorders 2013, 3:17-30
Published Date: 9 May 2013
Graves’ thyrotoxicosis following Hashimoto’s thyroiditis
Troisi A, Novati P, Sali L, Colzani M, Monti G, Cardillo C, Tesauro M
Research and Reports in Endocrine Disorders 2013, 3:13-15
Published Date: 13 March 2013
An update on the treatment of acromegaly
Edling KL, Heaney AP
Research and Reports in Endocrine Disorders 2013, 3:1-11
Published Date: 26 February 2013
Sustained biochemical control in patients with acromegaly treated with lanreotide depot 120 mg administered every 4 weeks, or an extended dosing interval of 6 or 8 weeks: a pharmacokinetic approach
Gomez-Panzani E, Chang S, Ramis J, Landolfi MM, Bakker B
Research and Reports in Endocrine Disorders 2012, 2:79-84
Published Date: 14 December 2012
Current and emerging treatments and surgical interventions for Morquio A syndrome: a review
Tomatsu S, Mackenzie WG, Theroux MC, Mason RW, Thacker MM, Shaffer TH, Montaño AM, Rowan D, Sly W, Alméciga-Díaz CJ, Barrera LA, Chinen Y, Yasuda E, Ruhnke K, Suzuki Y, Orii T
Research and Reports in Endocrine Disorders 2012, 2:65-77
Published Date: 12 December 2012
Emerging treatment options for the mucopolysaccharidoses
Giugliani R, Federhen A, Silva AA, Bittar CM, de Souza CF, Netto CB, Mayer FQ, Baldo G, Matte U
Research and Reports in Endocrine Disorders 2012, 2:53-64
Published Date: 6 November 2012
Optimizing glycemic control: clinical utility of exenatide prolonged release injection
Derosa G, Maffioli P
Research and Reports in Endocrine Disorders 2012, 2:41-51
Published Date: 26 September 2012
The endocrine effects of acylated and des-acylated ghrelin
Andrich DE, Cianflone K, Comtois AS, Lalonde S, St-Pierre DH
Research and Reports in Endocrine Disorders 2012, 2:31-40
Published Date: 27 August 2012
Optimal management of Cushing syndrome
Durán-Pérez EG, Moreno-Loza OT, Carrasco-Tobón G, Segovia-Palomo A
Research and Reports in Endocrine Disorders 2012, 2:19-30
Published Date: 21 June 2012
Update on the treatment of phenylketonuria: long-term safety and efficacy of sapropterin dihydrochloride
Vernon H
Research and Reports in Endocrine Disorders 2012, 2:11-17
Published Date: 6 June 2012
Detection accuracy of three glucose meters estimated by capillary blood glucose measurements compared with venous blood evaluated by the diabetes unit of the Hospital Evangélico de Curitiba, Brazil
Gama MP, Cruzeta CF, Ossowski AC, Bay MR, Michaelis MM, Camacho SL
Research and Reports in Endocrine Disorders 2012, 2:1-9
Published Date: 22 May 2012
Treatment of diabetic vasculopathy: an overview
Rahman S, Majumder MAA, Rahman ARA
Research and Reports in Endocrine Disorders 2011, 1:21-36
Published Date: 6 December 2011
Predicting response to incretin-based therapy
Kalra S, Kalra B, Sahay R, Agrawal N
Research and Reports in Endocrine Disorders 2011, 1:11-19
Published Date: 7 April 2011
Effect of protease inhibitors (indinavir and ritonavir) on the pharmacokinetics of gliclazide in rabbits
Kilari Eswar Kumar, Shaik Mastan
Research and Reports in Endocrine Disorders 2011, 1:1-9
Published Date: 20 January 2011